FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210634883> ?p ?o ?g. }

• W4210634883 abstract "Cytokine release syndrome (CRS) is a phenomenon of immune hyperactivation described in the setting of immunotherapy. Unlike other immune-related adverse events, CRS triggered by immune checkpoint inhibitors (ICIs) is not well described. The clinical characteristics and course of 25 patients with ICI-induced CRS from 2 tertiary hospitals were abstracted retrospectively from the medical records and analyzed. CRS events were confirmed by 2 independent reviewers and graded using the Lee et al. scale. The median duration of CRS was 15.0 days (Q1; Q3 6.3; 29.8) and 10 (40.0%) had multiple episodes of CRS flares. Comparing the clinical factors and biomarkers in Grades 1-2 and 3-5 CRS, we found that patients with Grades 3-5 CRS had following: (i) had longer time to fever onset [25.0 days (Q1; Q3 13.0; 136.5) vs. 3.0 days (Q1; Q3 0.0; 18.0), p=0.027]; (ii) more cardiovascular (p=0.002), neurologic (p=0.001), pulmonary (p=0.044) and rheumatic (p=0.037) involvement; (iii) lower platelet count (p=0.041) and higher urea (p=0.041) at presentation compared to patients with Grades 1-2 CRS. 7 patients (28.0%) with Grades 1-2 CRS were rechallenged using ICIs without event. 9 patients (36.0%) were treated with pulse methylprednisolone and 6 patients (24.0%) were treated with tocilizumab. Despite this, 3 patients (50%) who received tocilizumab had fatal (Grade 5) outcomes from ICI-induced CRS. Longer time to fever onset, lower platelet count and higher urea at presentation were associated with Grade 3-5 CRS. These parameters may be used to predict which patients are likely to develop severe CRS." @default.
• W4210634883 created "2022-02-08" @default.
• W4210634883 creator A5005318071 @default.
• W4210634883 creator A5030917613 @default.
• W4210634883 creator A5040482537 @default.
• W4210634883 creator A5057282202 @default.
• W4210634883 creator A5067069322 @default.
• W4210634883 creator A5069322746 @default.
• W4210634883 creator A5071979482 @default.
• W4210634883 creator A5072434302 @default.
• W4210634883 creator A5084222109 @default.
• W4210634883 creator A5086362466 @default.
• W4210634883 creator A5087090962 @default.
• W4210634883 date "2022-01-28" @default.
• W4210634883 modified "2023-10-01" @default.
• W4210634883 title "Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature" @default.
• W4210634883 cites W1505641753 @default.
• W4210634883 cites W2017200913 @default.
• W4210634883 cites W2041729438 @default.
• W4210634883 cites W2082708772 @default.
• W4210634883 cites W2110065044 @default.
• W4210634883 cites W2168803832 @default.
• W4210634883 cites W2177405394 @default.
• W4210634883 cites W2297174255 @default.
• W4210634883 cites W2340435799 @default.
• W4210634883 cites W2408097265 @default.
• W4210634883 cites W2513096128 @default.
• W4210634883 cites W2549756638 @default.
• W4210634883 cites W2551609581 @default.
• W4210634883 cites W2608424969 @default.
• W4210634883 cites W2620163654 @default.
• W4210634883 cites W2736166064 @default.
• W4210634883 cites W2755024608 @default.
• W4210634883 cites W2768429453 @default.
• W4210634883 cites W2771433910 @default.
• W4210634883 cites W2781493301 @default.
• W4210634883 cites W2786816161 @default.
• W4210634883 cites W2789465165 @default.
• W4210634883 cites W2793787928 @default.
• W4210634883 cites W2801513190 @default.
• W4210634883 cites W2807441801 @default.
• W4210634883 cites W2808166290 @default.
• W4210634883 cites W2889317689 @default.
• W4210634883 cites W2949901067 @default.
• W4210634883 cites W2975736685 @default.
• W4210634883 cites W2980687050 @default.
• W4210634883 cites W2997561837 @default.
• W4210634883 cites W3009244677 @default.
• W4210634883 cites W3015154527 @default.
• W4210634883 cites W3015607499 @default.
• W4210634883 cites W3021805222 @default.
• W4210634883 cites W3138656764 @default.
• W4210634883 cites W3162374648 @default.
• W4210634883 cites W3164758721 @default.
• W4210634883 cites W3174077356 @default.
• W4210634883 cites W3176452932 @default.
• W4210634883 cites W4254158468 @default.
• W4210634883 doi "https://doi.org/10.3389/fimmu.2022.807050" @default.
• W4210634883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35154124" @default.
• W4210634883 hasPublicationYear "2022" @default.
• W4210634883 type Work @default.
• W4210634883 citedByCount "21" @default.
• W4210634883 countsByYear W42106348832022 @default.
• W4210634883 countsByYear W42106348832023 @default.
• W4210634883 crossrefType "journal-article" @default.
• W4210634883 hasAuthorship W4210634883A5005318071 @default.
• W4210634883 hasAuthorship W4210634883A5030917613 @default.
• W4210634883 hasAuthorship W4210634883A5040482537 @default.
• W4210634883 hasAuthorship W4210634883A5057282202 @default.
• W4210634883 hasAuthorship W4210634883A5067069322 @default.
• W4210634883 hasAuthorship W4210634883A5069322746 @default.
• W4210634883 hasAuthorship W4210634883A5071979482 @default.
• W4210634883 hasAuthorship W4210634883A5072434302 @default.
• W4210634883 hasAuthorship W4210634883A5084222109 @default.
• W4210634883 hasAuthorship W4210634883A5086362466 @default.
• W4210634883 hasAuthorship W4210634883A5087090962 @default.
• W4210634883 hasBestOaLocation W42106348831 @default.
• W4210634883 hasConcept C121608353 @default.
• W4210634883 hasConcept C126322002 @default.
• W4210634883 hasConcept C197934379 @default.
• W4210634883 hasConcept C203014093 @default.
• W4210634883 hasConcept C2777178219 @default.
• W4210634883 hasConcept C2777701055 @default.
• W4210634883 hasConcept C2779134260 @default.
• W4210634883 hasConcept C2780372218 @default.
• W4210634883 hasConcept C2780850621 @default.
• W4210634883 hasConcept C3875195 @default.
• W4210634883 hasConcept C71924100 @default.
• W4210634883 hasConcept C8891405 @default.
• W4210634883 hasConcept C89560881 @default.
• W4210634883 hasConcept C90924648 @default.
• W4210634883 hasConceptScore W4210634883C121608353 @default.
• W4210634883 hasConceptScore W4210634883C126322002 @default.
• W4210634883 hasConceptScore W4210634883C197934379 @default.
• W4210634883 hasConceptScore W4210634883C203014093 @default.
• W4210634883 hasConceptScore W4210634883C2777178219 @default.
• W4210634883 hasConceptScore W4210634883C2777701055 @default.
• W4210634883 hasConceptScore W4210634883C2779134260 @default.
• W4210634883 hasConceptScore W4210634883C2780372218 @default.
• W4210634883 hasConceptScore W4210634883C2780850621 @default.

• next